DATIA LEADERSHIP Neil Fortner, Chairman Avee Laboratories
Phil Dubois, Chairman-Elect DrugScan Inc
Andrew Powell, Treasurer Nursing Corps, Inc.
Sherri Vogler, Secretary Houston Medical Testing Services
Diana Bauske Chem Chek Co. Inc.
Jim Bentley
Chromosomal Laboratories, Inc. Marian Bonner
Daniel DiThomas i3screen
Melissa DiThomas LexisNexis
Brian Drew Nationwide Medical Review
Barry Knott Lifeloc Technologies
Patricio Labatut Global Partners Ltda.
Robert McCormick Quest Diagnostics
Lisa Morrison-Bowles Compliance Resources Plus, LLC
Lisa Ruehle Interactive Medical Connections, Inc.
Scott Taillie Alere Toxicology
Elaine Taule NMS Management Services, Inc.
ADVERTISING To advertise in Focus, call 202.337.1893.
DESIGN & PRODUCTION Blue House Design
SUBMIT AN ARTICLE: DATIA Focus is the quarterly publication of the Drug & Alcohol Testing Industry Association. DATIA’s readership consists of industry professionals including collection facilities, laboratories, consortia/third party administrators, medical review officers, substance abuse professionals, hospitals, physician offices, treatment facilities, testing supply distributors and manufacturers, employers, government offices, and members of Congress. Our members provide services to over 1,000,000 employers and perform over 65,000,000 drug tests per year. If you believe that you have an idea or article of interest to our readers, please view the Author Submission Guidelines at
datia.org. You may also send inquiries and ideas to Laura Shelton, DATIA Executive Director, at
lshelton@datia.org.
Disclaimer: All Rights Reserved. Reproduction of this publication in any form without prior written permission is forbidden. The information contained herein has been obtained from sources believed to be reliable. The Drug & Alcohol Testing Industry Association (DATIA) disclaims all warranties as to the accuracy, completeness or adequacy of such information. DATIA shall have no liability for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The views and opinions expressed herein are those of the author and in no way represent the views or opinions of DATIA. The reader assumes sole responsibility for the selection of these materials to achieve its intended results. The opinions expressed herein are subject to change without notice.
contents winter 2013•Vol. 6 Issue 1 Compliance Oversight Solutions Ideal cover
8 Prescription Drugs: By the Numbers By Gary Patrone, ARCpoint Labs of Tempe
features
18 Synthetic Cannabinoids Prevalence in the Workplace: A Twelve-Month Evaluation by Clinical Reference Laboratory By David J. Kuntz, PhD, DABFT, Clinical Reference Laboratory
28 Planting the Seeds of Success: The Key to Effective Marketing through LinkedIn and Yelp By Serhat Pala, TestCountry
36 The Seductive Mirage of a 0.08 g/dL BAC Equivalent for Drugged Driving By Robert L. DuPont, MD, Gary M. Reisfield, MD, Bruce A. Goldberger, PhD, and Mark S. Gold, MD
departments 4 Letter From the Chairman
6 Letter From the Executive Director
14 Business Sense 24 Washington Report 25 Spotlight On 26 Getting to Know 34 Trends 44 Ask Alice 46 New Member List
Drug & Alcohol Testing Industry Association •1325 G Street, NW • Suite 500#5001 • Washington, DC 20005 phone: 800-355-1257 • fax: 202-315-3579 •
datia.org
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50